Digital Pharma and Marketing
As many pharmaceutical companies expand their consumer operations and roll out a variety of consumer brands, digital marketing will be the next frontier for them. Historically, tight regulatory limitations have stifled marketing innovation in the pharmaceutical sector. Since consumers exclusively relied on their healthcare practitioners for medical knowledge and guidance in the past, pharmaceutical corporations have had little to no connection with their end-users, or patients.
It is important to remember that people are using the internet more frequently to find answers to questions and problems rather than just to socialise online. In fact, looking for health-related information online ranks third in terms of popularity. Patients no longer take a passive approach to treatment these days.
- Digital Devices
- Digital Platforms
- Digital Media
- Digital Data
- Digital Technology
Related Conference of Digital Pharma and Marketing
7th World Congress on Advanced Clinical Trials and Clinical Research
4th International Forum on Pharmacovigilance and Regulatory Affairs
Digital Pharma and Marketing Conference Speakers
Recommended Sessions
- Pharmaceutical manufacturing and Pharmacoeconomics
- Advanced Pharmaceutical Technology
- Bioequivalence and Bioavailability
- Clinical Pharmacy and Pharmacy Practices
- Digital Pharma and Marketing
- Drug Discovery
- Drug Discovery
- Drug Discovery, Design & Development: Challenges and Approaches
- Nano medicine and Biomedical Application
- Novel Drug Delivery Systems, Biomarkers and Drug Targets
- Pharmaceutical Analysis
- Pharmaceutical Care and Health System
- Pharmaceutical Innovation
- Pharmaceutical Innovation
- Pharmaceutical Innovation
- Pharmaceutical Microbiology
- Pharmaceutical Nanotechnology
- Pharmacogenomics and Pharmacoepidemiology
- Pharmacology and Toxicology
- Technology in Pharma Sciences
- The future of Pharma R&D
Related Journals
Are you interested in
- Adaptive Trial Models - Clinical Trials Congress 2025 (Spain)
- Advanced Data Analytics - Clinical Trials Congress 2025 (Spain)
- Adverse Event Reporting through Mobile Health Tools - Euro Pharmacovigilance 2025 (Spain)
- AI in Clinical Research - Clinical Trials Congress 2025 (Spain)
- AI-Driven Signal Detection and Data Mining - Euro Pharmacovigilance 2025 (Spain)
- AI-Powered Pharmacovigilance - Clinical Trials Congress 2025 (Spain)
- Automation in Case Processing and Reporting - Euro Pharmacovigilance 2025 (Spain)
- Blockchain Applications - Clinical Trials Congress 2025 (Spain)
- Blockchain Applications in Regulatory Data Integrity - Euro Pharmacovigilance 2025 (Spain)
- Clinical Supply Chain Innovation - Clinical Trials Congress 2025 (Spain)
- Data Integrity & Compliance - Clinical Trials Congress 2025 (Spain)
- Decentralized Trials - Clinical Trials Congress 2025 (Spain)
- Digital Therapeutics Trials - Clinical Trials Congress 2025 (Spain)
- Digital Transformation in Drug Safety Operations - Euro Pharmacovigilance 2025 (Spain)
- Diversity in Enrollment - Clinical Trials Congress 2025 (Spain)
- eConsent & Retention Tools - Clinical Trials Congress 2025 (Spain)
- eSource & EDC Systems - Clinical Trials Congress 2025 (Spain)
- Ethics and Legal Challenges in Drug Safety Surveillance - Euro Pharmacovigilance 2025 (Spain)
- Global Harmonization of Regulatory Frameworks - Euro Pharmacovigilance 2025 (Spain)
- Global Regulatory Landscape - Clinical Trials Congress 2025 (Spain)
- Global Signal Management Systems and Standards - Euro Pharmacovigilance 2025 (Spain)
- Inspection Readiness and Audit Best Practices - Euro Pharmacovigilance 2025 (Spain)
- Integration of PV with Quality and Regulatory Affairs - Euro Pharmacovigilance 2025 (Spain)
- Managing Safety Data in Multi-Region Submissions - Euro Pharmacovigilance 2025 (Spain)
- Master Protocol Strategies - Clinical Trials Congress 2025 (Spain)
- Patient-Centric Designs - Clinical Trials Congress 2025 (Spain)
- Patient-Centric Pharmacovigilance Strategies - Euro Pharmacovigilance 2025 (Spain)
- Pharmacovigilance Compliance in Clinical Trials - Euro Pharmacovigilance 2025 (Spain)
- Pharmacovigilance in Accelerated Drug Approvals - Euro Pharmacovigilance 2025 (Spain)
- Pharmacovigilance in Gene and Cell Therapies - Euro Pharmacovigilance 2025 (Spain)
- Pharmacovigilance Outsourcing and Vendor Oversight - Euro Pharmacovigilance 2025 (Spain)
- Real-World Evidence in Post-Marketing Surveillance - Euro Pharmacovigilance 2025 (Spain)
- Real-World Evidence Integration - Clinical Trials Congress 2025 (Spain)
- Risk Management Planning and Benefit-Risk Assessment - Euro Pharmacovigilance 2025 (Spain)
- Risk-Based Monitoring - Clinical Trials Congress 2025 (Spain)
- Safety Labeling Changes and Regulatory Communication - Euro Pharmacovigilance 2025 (Spain)
- Safety Monitoring of Biologics and Biosimilars - Euro Pharmacovigilance 2025 (Spain)
- Synthetic Control Arms - Clinical Trials Congress 2025 (Spain)
- Virtual Trial Platforms - Clinical Trials Congress 2025 (Spain)
- Wearables & Remote Monitoring - Clinical Trials Congress 2025 (Spain)